GaIA Healthcare participating in the ISAM BUSAN 2018 meeting

GaIA Healthcare participating in the ISAM BUSAN 2018 meeting

ISAM Bousan 2018

We are very pleased to announce that GaIA Healthcare is participating in the ISAM BUSAN 2018 meeting.

We are organising a symposium on alcohol treatment pathways with invited speaker Dr Dimos Fotopoulos, Consultant Psychiatrist from Greece and vice-chair of the OKANA (Organisation Against Drugs of Greece). Dr Fotopoulos will talk about the state of treatment services for alcohol disorders in Greece.

Dr Christos Kouimtsidis of GaIA will talk about the ingredients of a successful community alcohol treatment service.

The symposium will take place on Sunday November the 4th at 13:50 (S38) Room 6.

For programme information visit: https://www.isam2018-busan.com/2017/english/03_program/01_program.asp

Prof Alex Baldacchino Advises the Maltese Government on Drug Strategy

Prof Alex Baldacchino Advises the Maltese Government on Drug Strategy

Prof Alex Baldacchino Advises the Maltese Government

Professor Alex Baldacchino was invited by the Maltese Government on the 29th June 2018 as an expert to help and advise the Maltese Drug Commission and associated stakeholders on national drug strategic and operational issues. Professor Baldacchino was greatly honoured to participate in this event which was held at the Maltese Parliament building in Valletta as he was, with colleagues, instrumental, 30 years ago in setting up the first ever drug treatment facility in Malta.

We have signed a teaming agreement with University of St. Andrews

We have signed a teaming agreement with University of St. Andrews

University of St Andrews

GaIA Healthcare Ltd and the University of St Andrews have signed a teaming agreement with the view to working closely to provide expertise, support and infrastructure in the field of addiction and mental health research activities and postgraduate education. The Board of Directors of GaIA Healthcare are delighted to enter into this agreement with St Andrews, recognised globally as a centre of excellence in tertiary education.

Drawing on our various offices and representations across Europe and the Middle East, this new venture allows us to broaden even further our reach with such a prestigious and internationally recognised institution.

 

Professor Riaz Khan, Chair of GaIA Healthcare Ltd.


GaIA Healthcare Ltd is a group of clinicians, interventionists and trainers.
European Opiate Addiction Treatment Association (EUROPAD)

European Opiate Addiction Treatment Association (EUROPAD)

The 2018 European Opiate Addiction Treatment Association (EUROPAD) takes place in Krakow, Poland

Professor Riaz Khan in collaboration with
the International Society of Addiction Medicine (ISAM)
organises the symposium titled

“Hot topics in Substance Use Disorder patients”

and talks alongside Dr Christos Kouimtsidis
at the 2018

European Opiate Addiction Treatment Association (EUROPAD)

on Sunday 27th of May at 12:00.

 

  • Prof Riaz Khan will give a talk on

Public health approach as the basis for addiction policy, the Swiss report on the challenge of addictions.

Current addiction policies in most European countries including Switzerland consist primarily of a range of separate policies on alcohol, tobacco and illegal psychoactive substances. There is little or no coordination between these policy sectors.

The Swiss report on the Challenge of Addiction is a contribution towards an integrated understanding of the addiction dilemma. The report highlights the basis of a public health approach as the fundamental foundation for an addiction policy. From a health policy perspective, the aim is to broaden the scope of addiction policy in Switzerland by its strategic focus and system towards delivering services.

The report recommends ten principles which are intended to contribute to a coherent policy response to the problematic use of all psychoactive substances and to behaviours with addictive potential.

 

  • Dr Christos Kouimtsidis will address the issue:

Could and should Cognitive Behaviour models being applied across substance misuse groups; are there more differences than commonalities?

Cognitive Behaviour Therapy models are used in the treatment of addictions across different substances of abuse although there is little evidence available to support such approach.  These models are based on Expectancy theory which argues that positive outcome expectancies and negative outcome expectancies are important for the initiation, maintenance and recovery from addiction.

Despite the above common theoretical background measuring instruments for basic concepts such as outcome expectancies have been developed and validated for each of the substances separately.

In this session we present data from the first ever attempt to develop an outcome expectancies questionnaire for smokers, alcohol, opioid and stimulant users in treatment (Substance Use Beliefs Questionnaire). Furthermore we will discuss if these data support the propositions about the assumed causal relationships deduced from Cognitive Behaviour Therapy models and they support one model better than others for each one of the substance groups.